Ariad Pharmaceuticals, Inc.

NASDAQ: ARIA
$23.99
+$0.00 (+0.0%)
Closing price February 17, 2017
Thursday's top analyst upgrades and downgrades from 24/7 Wall St. include ARIAD Pharmaceuticals, FedEx, Genpact, Suncor Energy, Travelers and UPS.
Source: ThinkstockEarnings season is winding down and the markets remain choppy. Investors are wary, but they want upside and they keep hearing that this is now a stock picker’s market. 24/7 Wall...
Source: ThinkstockStocks are indicated lower on Monday, with the S&P 500 futures down seven points at 1,867.50 and DJIA futures down 61 points around 16,386. Investors and traders alike are still...
These are the top analyst upgrades, downgrades and initiations seen on Monday, May 5, 2014. They include ARIAD Pharmaceuticals, Chipotle Mexican Grill, Disney, FireEye, L-3 Communications and SINA.
Ariad Pharmaceuticals could be joining the ranks of the next big biotech acquisitions. The company fits the bill of many biotech acquirers because its market cap is just over $1 billion and its...
These are the top analyst downgrades and cautious research notes from Wall Street for Monday, January 6.
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms Monday, December 23, 2013.
The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.
Source: ThinkstockNearly 39 million shares of Ariad Pharmaceuticals Inc. (NASDAQ: ARIA) have traded hands as of 11:30 a.m. Tuesday morning, nearly triple the stock’s average daily volume of around...
Source: ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ: SHPG) will acquire the rare disease biopharmaceutical...
Source: ThinkstockThings just keep getting worse for Ariad Pharmaceuticals Inc. (NASDAQ: ARIA). In fact, a series of shareholder revolts are probably in the works here after yet another massive drop...
Source: Jon OggStocks are at all-time highs now that a deal has been reached in Washington, D.C., and investors have to wonder which stocks are set to keep rising and which ones may have overstayed...
Source: ThinkstockBiotech and emerging health care technology companies both fit into a high-stake poker match on Wall Street. Investors can earn exponential rewards if they are right, or they can...
Source: Jon OggEarnings season has officially started, but the stock market and bond market are both dealing with the government shutdown, an upcoming debt ceiling and even the announcement of a new...
Source: via Wikimedia CommonsAriad Pharmaceuticals Inc. (NASDAQ: ARIA) is getting crushed on Wednesday due to a clinical hold placed by the U.S. Food & Drug Administration. The company confirmed that...